Abstract:The role of long noncoding RNA (lncRNA) in tumors, particularly in gastrointestinal tumors, has gained significant attention. Accumulating evidence underscores the interaction between various lncRNAs and diverse molecular pathways involved in cancer progression. One such pivotal pathway is the PI3K/AKT pathway, which serves as a crucial intracellular mechanism maintaining the balance among various cellular physiological processes for normal cell growth and survival. Frequent dysregulation of the PI3K/AKT pathway in cancer, along with aberrant activation, plays a critical role in driving tumorigenesis. LncRNAs modulate the PI3K/AKT signaling pathway through diverse mechanisms, primarily by acting as competing endogenous RNA to regulate miRNA expression and associated genes. This interaction significantly influences fundamental biological behaviors such as cell proliferation, metastasis, and drug resistance. Abnormal expression of numerous lncRNAs in gastrointestinal tumors often correlates with clinical outcomes and pathological features in patients with cancer. Additionally, these lncRNAs influence the sensitivity of tumor cells to chemotherapy in multiple types of gastrointestinal tumors through the abnormal activation of the PI3K/AKT pathway. These findings provide valuable insights into the mechanisms underlying gastrointestinal tumors and potential therapeutic targets. However, gastrointestinal tumors remain a significant global health concern, with increasing incidence and mortality rates of gastrointestinal tumors over recent decades. This review provides a comprehensive summary of the latest research on the interactions of lncRNA and the PI3K/AKT pathway in gastrointestinal tumor development. Additionally, it focuses on the functions of lncRNAs and the PI3K/AKT pathway in carcinogenesis, exploring expression profiles, clinicopathological characteristics, interaction mechanisms with the PI3K/AKT pathway, and potential clinical applications.

To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway

Crosstalk Between Circrnas and the PI3K/AKT And/or MEK/ERK Signaling Pathways in Digestive Tract Malignancy Progression.

PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment

PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress.

The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles

Targeting PI3K in cancer: mechanisms and advances in clinical trials

PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?

Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells

Targeting the JAK-STAT pathway in colorectal cancer: mechanisms, clinical implications, and therapeutic potential

Targeting PI3K/Akt signal transduction for cancer therapy

Crosstalk between circRNAs and the PI3K/AKT and/or MEK/ERK signaling pathways in digestive tract malignancy progression

Mechanisms and prospects of circular RNAs and their interacting signaling pathways in colorectal cancer

Research progress of small molecule inhibitors targeting PI3K-Akt-mTOR pathway

Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer

Research progress on the PI3K/AKT signaling pathway in gynecological cancer

Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways

Targeting PI3K/Akt/mTOR Signaling in Cancer

PI3K/AKT signaling pathway and cancer: an updated review

The essential roles of lncRNAs/PI3K/AKT axis in gastrointestinal tumors